Table 1.
Methods for identifying paired TCR chains.
| Technique | Beta % | Alpha % | Paired % | Amplified TCR regions | Strengths | Major limitations | Reference |
|---|---|---|---|---|---|---|---|
| PCR-based | N/A | 35% | N/A | Full variable region | Limited number of primers | Low throughput Gives a limited assessment of TCR repertoire PCR product is not directly conducive with cloning |
Ozawa et al., (2008) |
| PCR-based 5′-RACE | N/A | N/A | N/A | Full TCR chain | High throughput Compatible with subsequent in vitro studies |
Fully human TCR construct, not compatible with in vivo mouse expression | Walchli et al., (2011) |
| PCR-based | 55–75% | 45–65% | N/A | CDR3 | Limited number of primers | Low throughput Gives a limited assessment of TCR repertoire PCR product is not directly conducive with cloning |
Dash et al., (2011) |
| PCR-based | 27–85% | N/A | 39% | CDR3 | Limited number of primers | Low throughput PCR product is not directly conducive with cloning |
Kim et al., (2012) |
| PCR-based | 67% | 61% | 43% | Full TCR chain | Combines TCR identification with phenotype | Fully human TCR construct, not compatible with in vivo mouse expression | Eugster et al., (2013) |
| Gene capture | 100% | 100% | 100% | N/A | High throughput | Necessary to generate T cell clones to identify Tcra and Tcrb genes Requires in silico assembly and de novo TCR construction |
Linnemann et al., (2013) |
| Emulsion PCR | N/A | N/A | N/A | CDR3 | High throughput Limited number of primers |
PCR product is not directly conducive with cloning | Turchaninova et al., (2013) |
| PCR-based | N/A | N/A | 13–72% | Full TCR chain | Limited number of primers Compatible with subsequent in vitro studies |
Alpha and beta chains are cloned into separate vectors, non-stoichiometric expression Fully human TCR construct, not compatible with in vivo mouse expression |
Kobayashi et al., (2013) |
| PCR-based | 81–92% | 87% | 58–82% | CDR3 | High throughput Combines TCR identification with phenotype |
PCR product is not directly conducive with cloning | Han et al., (2014) |
| PCR-based | N/A | N/A | N/A | CDR3 | Limited number of primers | Low throughput PCR product is not directly conducive with cloning Requires in silico assembly and de novo TCR construction Fully human TCR construct, not compatible with in vivo mouse expression |
Guo et al., (2016) |
| RNA-seq | 88–96% | 74–96% | 70–93% | Full TCR chain | High throughput Combines TCR identification with gene expression profile |
RNA-seq is a prohibitive technique for many labs due to the associated cost TCR sequence information only, would require synthesizing TCR construct for expression (costly) |
Stubbington et al., (2016) |
| Current protocol | |||||||
| PCR-based | 63–89% | 49–60% | 45–59% | Full variable region | Compatible with subsequent in vitro and in vivo studies | Low throughput Gives a limited assessment of TCR repertoire |
|
N/A = not available.